Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 24;18(1):25.
doi: 10.1186/s12905-017-0493-9.

Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana

Antoine Adenis  1 , Valentin Dufit  1 , Maylis Douine  1 , Jerome Ponty  1 , Laure Bianco  1 , Fatiha Najioullah  2 , Odile Kilié  2 , Dominique Catherine  3 , Nadia Thomas  4 , Jean Luc Deshayes  5 , Paul Brousse  6 , Gabriel Carles  7 , Claire Grenier  6 , Vincent Lacoste  8 , Vincent Molinie  3 , Raymond Cesaire  2 , Mathieu Nacher  9   10
Affiliations

Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana

Antoine Adenis et al. BMC Womens Health. .

Abstract

Background: Cervical cancer prevention using cervical cytology is insufficiently sensitive, a significant proportion of HPV-infected women having normal cytology. The objective of the present study was to try to identify factors associated with abnormal cytology in HPV-infected women living in remote areas of French Guiana.

Methods: A study was conducted in women aged 20-65 years having HPV infections confirmed by HPV DNA detection using the GREINER-BIO-ONE kit. In addition to HPV testing, cytology was performed and classified as normal or abnormal. Demographic and life history variables, and infecting genotypes were compared between the normal and abnormal cytology groups.

Results: None of the demographic and life history variables were associated with cytology results. HPV genotype 53 was significantly associated with absence of cytological abnormalities whereas HPV 52, 58, 16 and perhaps 33 and 66 were independently associated with a greater risk of cytological abnormalities. When grouping HPV genotypes in different species, only species 9 (HPV 16, 31, 33, 35, 52, 58, 67) was significantly associated with abnormal cytology AOR = 5.1 (95% CI = 2.3-11.2), P < 0.001.

Conclusions: It was not possible to predict which HPV-infected women will have cytological abnormalities or notfrom anamnesis. In this study HPV 53 seemed more benign than other HPV genotypes. On the contrary, species n°9, containing 5 of the genotypes contained in the nonavalent HPV vaccine, was significantly associated with more cytological abnormalities. HPV testing and vaccination with the nonavalent vaccine should be implemented in these remote parts of French Guiana.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Aproval was given by the Comité d’Evaluation Ethique de l’Inserm (CEEI), approval n° 12–064; the Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la Santé (CCTIRS), n° 12.310; the Commission Nationale de l’Informatique et des Libertés (CNIL), n° 912,459.

Consent for publication

All women gave informed consent to publish the results from the study.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
a and b show the proportion with cytological abnormalities and with normal cytology results by infecting HPV genotype for carcinogenic HPV genotypes and possibly carcinogenic HPV genotypes
See this image and copyright information in PMC

References

    1. Roue T, Nacher M, Fior A, Plenet J, Belliardo S, Gandolfo N, Deshayes JL, Laborde O, Carles G, Thomas N, et al. Cervical cancer incidence in French Guiana: south American. Int J Gynecol Cancer. 2012;22(5):850–853. doi: 10.1097/IGC.0b013e318251722c. - DOI - PubMed
    1. Douine M, Roue T, Fior A, Adenis A, Thomas N, Nacher M. Survival of patients with invasive cervical cancer in French Guiana, 2003-2008. Int J Gynaecology Obstetrics: Official Organ Int Federation Gynaecology Obstetrics. 2014;125(2):166–167. doi: 10.1016/j.ijgo.2013.10.031. - DOI - PubMed
    1. Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex. 2003;45(Suppl 3):S306–S314. - PubMed
    1. Douine M, Roue T, Lelarge C, Adenis A, Thomas N, Nacher M. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011. Bull Soc Pathol Exot. 2015;108(5):355–359. doi: 10.1007/s13149-015-0460-3. - DOI - PubMed
    1. Adenis A, Dufit V, Douine M, Corlin F, Ayhan G, Najioullah F, Molinie V, Brousse P, Carles G, Lacoste V. High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study. Epidemiology & Infection. 2017;145(6):1276–1284. doi: 10.1017/S0950268816003319. - DOI - PMC - PubMed

Publication types

MeSH terms